Key facts
- It has raised $130K; the latest was Seed Round in Nov 2025.
- Notable investors include Plug and Play Tech Center, VentureWell, Bioincubator, MESH Incubator, Mass Innovation Network — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Microvitality
- ·The full record, as it builds
Funding rounds
No funding rounds for Microvitality are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Microvitality
Developer of a novel capsule designed to provide precise, non-invasive, and uncontaminated sampling of the small intestine. The company's capsule technology is designed to provides small intestine data through a fluid biopsy across scientific disciplines, ensures groundbreaking microbiome discoveries and targeted therapeutic approaches and delivers non-invasive and safe sampling, enabling users to get reliable and uncontaminated data and transform microbiome research into actionable insights.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2023
- Employees
- 4
- Website
- microvitalitybio.com/
- Ownership
- Privately Held (backing)
Microvitality doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Microvitality shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Microvitality in its N-PORT filings yet. We sweep new filings monthly.